These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2279525

  • 1. Blood-spot 17-hydroxyprogesterone daily profiles in infants with congenital adrenal hyperplasia.
    Sólyom J, Hosszu E, Gács G.
    Exp Clin Endocrinol; 1990 Sep; 96(1):52-6. PubMed ID: 2279525
    [Abstract] [Full Text] [Related]

  • 2. Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.
    Sólyom J.
    Arch Dis Child; 1984 Aug; 59(8):743-7. PubMed ID: 6541026
    [Abstract] [Full Text] [Related]

  • 3. Age of appearance of circadian rhythm in blood 17-hydroxyprogesterone in 21-hydroxylase deficiency.
    Sólyom J.
    Acta Physiol Hung; 1991 Aug; 78(2):107-10. PubMed ID: 1808976
    [Abstract] [Full Text] [Related]

  • 4. 170H-progesterone rhythms in congenital adrenal hyperplasia.
    Young MC, Robinson JA, Read GF, Riad-Fahmy D, Hughes IA.
    Arch Dis Child; 1988 Jun; 63(6):617-23. PubMed ID: 3389891
    [Abstract] [Full Text] [Related]

  • 5. Blood-spot 17 alpha-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia.
    Sólyom J.
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):547-53. PubMed ID: 7296904
    [Abstract] [Full Text] [Related]

  • 6. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE, Sizonenko PC.
    Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
    [Abstract] [Full Text] [Related]

  • 7. Radioimmunoassay of blood-spot 17 alpha-hydroxyprogesterone in the management of congenital adrenal hyperplasia.
    Robinson JA, Dyas J, Hughes IA, Riad-Fahmy D.
    Ann Clin Biochem; 1987 Jan; 24 ( Pt 1)():58-65. PubMed ID: 3827186
    [Abstract] [Full Text] [Related]

  • 8. Screening for congenital adrenal hyperplasia: distribution of 17 alpha-hydroxyprogesterone concentrations in neonatal blood spot specimens.
    Thompson R, Seargeant L, Winter JS.
    J Pediatr; 1989 Mar; 114(3):400-4. PubMed ID: 2784166
    [Abstract] [Full Text] [Related]

  • 9. Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.
    Frisch H, Parth K, Schober E, Swoboda W.
    Arch Dis Child; 1981 Mar; 56(3):208-13. PubMed ID: 7212759
    [Abstract] [Full Text] [Related]

  • 10. Response to treatment of congenital adrenal hyperplasia in infancy.
    Young MC, Hughes IA.
    Arch Dis Child; 1990 Apr; 65(4):441-4. PubMed ID: 2346339
    [Abstract] [Full Text] [Related]

  • 11. 17-Hydroxyprogesterone rhythms and growth velocity in congenital adrenal hyperplasia.
    Pincus DR, Kelnar CJ, Wallace AM.
    J Paediatr Child Health; 1993 Aug; 29(4):302-4. PubMed ID: 8373678
    [Abstract] [Full Text] [Related]

  • 12. [Neonatal levels of 17-hydroxyprogesterone--early diagnosis of adrenogenital syndrome].
    Sulcová J, Tichá H, Wiererová O.
    Cesk Pediatr; 1989 Dec; 44(12):716-8. PubMed ID: 2636556
    [Abstract] [Full Text] [Related]

  • 13. Circadian variation in plasma 17-hydroxyprogesterone in patients with congenital adrenal hyperplasia.
    Atherden SM, Barnes ND, Grant DB.
    Arch Dis Child; 1972 Aug; 47(254):602-4. PubMed ID: 5046776
    [Abstract] [Full Text] [Related]

  • 14. Elevated 17-hydroxyprogesterone and testosterone in a newborn with 3-beta-hydroxysteroid dehydrogenase deficiency.
    Cara JF, Moshang T, Bongiovanni AM, Marx BS.
    N Engl J Med; 1985 Sep 05; 313(10):618-21. PubMed ID: 3160950
    [No Abstract] [Full Text] [Related]

  • 15. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
    Pang S, MacGillivray M, Wang M, Jeffries S, Clark A, Rosenthal I, Wiegensberg M, Riddick L.
    J Clin Endocrinol Metab; 1991 Jul 05; 73(1):166-74. PubMed ID: 2045467
    [Abstract] [Full Text] [Related]

  • 16. Inappropriate adrenal androgen secretion with once-a-day corticosteroid therapy for congenital adrenal hyperplasia.
    Keenan BS, Eberle AE, Lin TH, Clayton GW.
    J Pediatr; 1990 Jan 05; 116(1):133-6. PubMed ID: 2153199
    [Abstract] [Full Text] [Related]

  • 17. Bloodspot 17 alpha-hydroxyprogesterone radioimmunoassay for diagnosis of congenital adrenal hyperplasia and home monitoring of corticosteroid replacement therapy.
    Riordan FA, Wood PJ, Wakelin K, Betts P, Clayton BE.
    Lancet; 1984 Mar 31; 1(8379):708-11. PubMed ID: 6143043
    [Abstract] [Full Text] [Related]

  • 18. [17-hydroxyprogesterone, testosterone and androstenedione in treated congenital adrenogenital syndrome].
    von Schnakenburg K, Bidingmaier F, Knorr D.
    Monatsschr Kinderheilkd (1902); 1977 May 31; 125(5):579-80. PubMed ID: 876244
    [No Abstract] [Full Text] [Related]

  • 19. A bloodspot androstenedione assay suitable for home-monitoring of steroid replacement therapy in congenital adrenal hyperplasia.
    Egan SM, Betts P, Thomson S, Wallace AM, Wood PJ.
    Ann Clin Biochem; 1989 May 31; 26 ( Pt 3)():262-7. PubMed ID: 2669617
    [Abstract] [Full Text] [Related]

  • 20. Morning steroid profile in children with congenital adrenal hyperplasia under different hydrocortisone schedules.
    Silva IN, Oliveira-Júnior DF, Simal CJ, Viana MB, Chagas AJ.
    Indian J Pediatr; 1994 May 31; 61(4):341-6. PubMed ID: 8002061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.